Dr. Sandeep Mashru
Claim this profileKaiser Permanente Northwest
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
12 reported clinical trials
34 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
KRAS positive
MET positive
2Lung Cancer
Stage IV
KRAS positive
MET positive
Affiliated Hospitals
Clinical Trials Sandeep Mashru is currently running
Lomustine + Standard Therapy
for Glioblastoma
This phase III trial compares the effect of adding lomustine to standard chemotherapy with temozolomide and radiation therapy versus temozolomide and radiation therapy alone in shrinking or stabilizing newly diagnosed MGMT methylated glioblastoma. MGMT methylated tumors are more likely to respond to temozolomide chemotherapy. Temozolomide is in a class of medications called alkylating agents. It works by damaging the cell's DNA and may kill tumor cells and slow down or stop tumor growth. Lomustine is a chemotherapy drug and in a class of medications called alkylating agents. It damages the cell's DNA and may kill tumor cells. Radiation therapy uses high energy x-ray photons to kill tumor cells and shrink tumors. Adding lomustine to standard chemotherapy with temozolomide and radiation therapy may shrink or stabilize glioblastoma.
Recruiting2 awards Phase 34 criteria
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting1 award Phase 314 criteria
More about Sandeep Mashru
Clinical Trial Related3 years of experience running clinical trials · Led 12 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Sandeep Mashru has experience with
- Pembrolizumab
- Nivolumab
- Ipilimumab
- Cisplatin
- Carboplatin
- Pemetrexed
Breakdown of trials Sandeep Mashru has run
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sandeep Mashru specialize in?
Sandeep Mashru focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Sandeep Mashru currently recruiting for clinical trials?
Yes, Sandeep Mashru is currently recruiting for 6 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Sandeep Mashru has studied deeply?
Yes, Sandeep Mashru has studied treatments such as Pembrolizumab, Nivolumab, Ipilimumab.
What is the best way to schedule an appointment with Sandeep Mashru?
Apply for one of the trials that Sandeep Mashru is conducting.
What is the office address of Sandeep Mashru?
The office of Sandeep Mashru is located at: Kaiser Permanente Northwest, Portland, Oregon 97227 United States. This is the address for their practice at the Kaiser Permanente Northwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.